Chelsey J F Smith1, Frauke Förger2, Gretchen Bandoli3, Christina D Chambers3. 1. University of California San Diego, La Jolla, and Cedars-Sinai Medical Center, Los Angeles, California. 2. University Hospital and University of Bern, Bern, Switzerland. 3. University of California San Diego, La Jolla.
Abstract
OBJECTIVE: Pregnant women with inflammatory arthritis may be at increased risk for preterm delivery (PTD), yet it is unclear what drives this risk. This aim of this prospective cohort study of pregnant women with rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA), or healthier comparison women was to analyze the independent effects of maternal disease activity, medication use, and comorbid pregnancy conditions on PTD risk. METHODS: Women were enrolled before 19 weeks completed gestation as part of the Organization of Teratology Information Specialists (OTIS) Autoimmune Disease in Pregnancy Project. Data on pregnancy events, medications, disease activity, and outcomes were obtained by maternal report and validated by medical records. Poisson regression with robust standard errors estimated risk ratios (RR), multivariable adjusted risk ratios (ARRs), and 95% confidence intervals (95% CIs). RESULTS: A total of 657 women with RA, 170 with JIA, and 564 comparison women without autoimmune disease who delivered live born infants, from 2004 to 2017 were included for analysis. Both the RA and JIA groups had an increased risk of PTD versus the comparison group (RR 2.09 [95% CI 1.50-2.91] and RR 1.81 [95% CI 1.14-2.89], respectively). Active RA at enrollment (ARR 1.58 [95% CI 1.10-2.27]) and any time during pregnancy (ARR 1.52 [95% CI 1.06-2.18]) was associated with PTD. Corticosteroid use in every trimester was associated with an approximate 2- to 5-fold increased risk for PTD for both arthritis groups, independent of disease activity. CONCLUSION: Women with RA and women with JIA are at increased risk for PTD. Maternal disease activity and corticosteroid use may contribute to some of this excess risk.
OBJECTIVE: Pregnant women with inflammatory arthritis may be at increased risk for preterm delivery (PTD), yet it is unclear what drives this risk. This aim of this prospective cohort study of pregnant women with rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA), or healthier comparison women was to analyze the independent effects of maternal disease activity, medication use, and comorbid pregnancy conditions on PTD risk. METHODS:Women were enrolled before 19 weeks completed gestation as part of the Organization of Teratology Information Specialists (OTIS) Autoimmune Disease in Pregnancy Project. Data on pregnancy events, medications, disease activity, and outcomes were obtained by maternal report and validated by medical records. Poisson regression with robust standard errors estimated risk ratios (RR), multivariable adjusted risk ratios (ARRs), and 95% confidence intervals (95% CIs). RESULTS: A total of 657 women with RA, 170 with JIA, and 564 comparison women without autoimmune disease who delivered live born infants, from 2004 to 2017 were included for analysis. Both the RA and JIA groups had an increased risk of PTD versus the comparison group (RR 2.09 [95% CI 1.50-2.91] and RR 1.81 [95% CI 1.14-2.89], respectively). Active RA at enrollment (ARR 1.58 [95% CI 1.10-2.27]) and any time during pregnancy (ARR 1.52 [95% CI 1.06-2.18]) was associated with PTD. Corticosteroid use in every trimester was associated with an approximate 2- to 5-fold increased risk for PTD for both arthritis groups, independent of disease activity. CONCLUSION:Women with RA and women with JIA are at increased risk for PTD. Maternal disease activity and corticosteroid use may contribute to some of this excess risk.
Authors: M Nørgaard; H Larsson; L Pedersen; F Granath; J Askling; H Kieler; A Ekbom; H T Sørensen; O Stephansson Journal: J Intern Med Date: 2010-10 Impact factor: 8.989
Authors: Marianne Wallenius; Johan F Skomsvoll; Lorentz M Irgens; Kjell Å Salvesen; Bjorn Y Nordvåg; Wenche Koldingsnes; Knut Mikkelsen; Cecilie Kaufmann; Tore K Kvien Journal: Arthritis Rheum Date: 2011-06
Authors: Elizabeth S Langen; Eliza F Chakravarty; Maryam Liaquat; Yasser Y El-Sayed; Maurice L Druzin Journal: Am J Perinatol Date: 2013-01-28 Impact factor: 1.862
Authors: Elisabeth Balstad Magnussen; Lars Johan Vatten; Tom Ivar Lund-Nilsen; Kjell Asmund Salvesen; George Davey Smith; Pål Richard Romundstad Journal: BMJ Date: 2007-11-01
Authors: Yaël A de Man; Johanna M W Hazes; Hugo van der Heide; Sten P Willemsen; Christianne J M de Groot; Eric A P Steegers; Radboud J E M Dolhain Journal: Arthritis Rheum Date: 2009-11
Authors: Chelsey J F Smith; Gretchen Bandoli; Arthur Kavanaugh; Christina D Chambers Journal: Arthritis Care Res (Hoboken) Date: 2020-06-11 Impact factor: 4.794
Authors: Ryan Malcolm Hum; Trixy David; Yen June Lau; Hajira Iftikhar; Sue Thornber; Louise Simcox; Ian Bruce; Clare Tower; Pauline Ho Journal: Rheumatol Adv Pract Date: 2022-03-28